| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/16/2023 | 21.8% | Susquehanna | → $50 | Upgrades | Neutral → Positive |
| 09/22/2023 | 2.31% | B of A Securities | $40 → $42 | Maintains | Underperform |
| 09/07/2023 | -2.56% | Wells Fargo | $48 → $40 | Downgrades | Overweight → Equal-Weight |
| 06/30/2023 | 16.93% | Wells Fargo | $37 → $48 | Maintains | Overweight |
| 04/14/2023 | -19.61% | B of A Securities | $35 → $33 | Maintains | Underperform |
| 04/13/2023 | -19.61% | Susquehanna | $30 → $33 | Maintains | Neutral |
| 04/11/2023 | -14.74% | B of A Securities | $30 → $35 | Maintains | Underperform |
| 04/11/2023 | -7.43% | Stephens & Co. | $36 → $38 | Maintains | Overweight |
| 01/17/2023 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 11/07/2022 | -9.87% | Susquehanna | $30 → $37 | Downgrades | Positive → Neutral |
| 07/13/2022 | 14.49% | Cowen & Co. | $54 → $47 | Maintains | Outperform |
| 07/12/2022 | -7.43% | Susquehanna | $58 → $38 | Maintains | Positive |
| 04/07/2022 | 43.73% | Stephens & Co. | $63 → $59 | Maintains | Overweight |
| 12/10/2021 | 36.42% | Stephens & Co. | $41 → $56 | Upgrades | Equal-Weight → Overweight |
| 07/26/2021 | 36.42% | Susquehanna | → $56 | Upgrades | Neutral → Positive |
| 07/12/2021 | 26.67% | B of A Securities | $45 → $52 | Upgrades | Underperform → Buy |
| 08/27/2020 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 07/13/2020 | -41.53% | Susquehanna | $13 → $24 | Upgrades | Negative → Neutral |
| 04/15/2020 | -39.1% | Cowen & Co. | $38 → $25 | Maintains | Outperform |
| 04/08/2020 | -26.92% | Keybanc | $38 → $30 | Maintains | Overweight |
| 04/03/2020 | -58.59% | Wells Fargo | $28 → $17 | Maintains | Underweight |
| 01/14/2020 | — | Wells Fargo | Downgrades | Equal-Weight → Underweight | |
| 01/09/2020 | -31.79% | Wells Fargo | $31 → $28 | Maintains | Equal-Weight |
| 09/16/2019 | -7.43% | Keybanc | → $38 | Upgrades | Sector Weight → Overweight |
| 07/24/2019 | -48.84% | Buckingham Research | $34 → $21 | Downgrades | Neutral → Underperform |
| 03/27/2019 | -9.87% | Buckingham Research | $41 → $37 | Maintains | Neutral |
| 03/11/2019 | 51.04% | Keybanc | → $62 | Downgrades | Overweight → Sector Weight |
| 01/10/2019 | 14.49% | B of A Securities | $56 → $47 | Reiterates | Buy → Buy |
| 11/29/2018 | 51.04% | Keybanc | $68 → $62 | Maintains | Overweight |
| 10/29/2018 | 36.42% | Buckingham Research | $55 → $56 | Maintains | Neutral |
| 10/29/2018 | 26.67% | Wells Fargo | $55 → $52 | Maintains | Market Perform |
| 10/29/2018 | — | Susquehanna | Upgrades | Neutral → Positive |
What is the target price for Greenbrier Companies (GBX)?
The latest price target for Greenbrier Companies (NYSE: GBX) was reported by Susquehanna on October 16, 2023. The analyst firm set a price target for $50.00 expecting GBX to rise to within 12 months (a possible 21.80% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Greenbrier Companies (GBX)?
The latest analyst rating for Greenbrier Companies (NYSE: GBX) was provided by Susquehanna, and Greenbrier Companies upgraded their positive rating.
When is the next analyst rating going to be posted or updated for Greenbrier Companies (GBX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Greenbrier Companies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Greenbrier Companies was filed on October 16, 2023 so you should expect the next rating to be made available sometime around October 16, 2024.
Is the Analyst Rating Greenbrier Companies (GBX) correct?
While ratings are subjective and will change, the latest Greenbrier Companies (GBX) rating was a upgraded with a price target of $0.00 to $50.00. The current price Greenbrier Companies (GBX) is trading at is $41.05, which is within the analyst's predicted range.